FAD shares many features, pathophysiologically and clinically, with the more common sporadic form of disease.13 FAD mutation carriers have relatively predictable ages at onset,14 which allows prospective study of individuals prior to onset of clinical AD. The gene discussed is PSEN1; the disease is Alzheimer disease.